These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21859897)

  • 1. Treatment of thyroid cancer with the new oral agents.
    Galofré JC; Gómez-Sáez JM; Escola CA; Anda E; Calleja A; Donnay S; Lucas-Martin A; Menéndez-Torre E; Pereg V; Pérez-Corral B; Santamaría J; Riesco-Eizaguirre G; Zafon C;
    Ann Oncol; 2011 Oct; 22(10):2343. PubMed ID: 21859897
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): positioning statement from the Spanish Association of Urology.
    Villavicencio H; Hernández C; Gómez A; Cózar JM; Rodríguez-Antolín A; Prieto L; de Cabo M; Malet JM; Extramiana J; Mata J; Arrabal M; Server G; Solsona E; Del Valle JI; Miguélez E; Gutiérrez E; Elizalde A; Mateos J; Artiles JL; Jiménez-Cidre M; Nalda LM; Cruz N; Ozonas M; Caffaratti J; Esteban M; Unda M; Reina C; Alvarez-Ossorio JL; Lledó E; Angulo JC
    Actas Urol Esp; 2013 Jun; 37(6):321-3. PubMed ID: 23706692
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM).
    Colomer R; Alba E; González-Martin A; Paz-Ares L; Martín M; Llombart A; Rodríguez Lescure Á; Salvador J; Albanell J; Isla D; Lomas M; Rodríguez CA; Trigo JM; Germà JR; Bellmunt J; Tabernero J; Rosell R; Aranda E; Cubedo R; Baselga J;
    Ann Oncol; 2010 Feb; 21(2):195-198. PubMed ID: 20110291
    [No Abstract]   [Full Text] [Related]  

  • 4. Erythropoiesis-stimulating agents in cancer patients: ESMO recommendations for use.
    Scrijvers D; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():159-61. PubMed ID: 19454443
    [No Abstract]   [Full Text] [Related]  

  • 5. MASCC Oral Agent Teaching Tool (MOATT): yesterday, today and tomorrow.
    Lemonde M
    Can Oncol Nurs J; 2014; 24(3):207-10. PubMed ID: 25189059
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up.
    Van Cutsem E; Oliveira J;
    Ann Oncol; 2009 May; 20 Suppl 4():49-50. PubMed ID: 19454461
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer protocols.
    Oxley DK; Uthman EO
    Arch Pathol Lab Med; 2011 Mar; 135(3):289-90. PubMed ID: 21366446
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Pentheroudakis G; Pavlidis N; Castiglione M;
    Ann Oncol; 2009 May; 20 Suppl 4():178-81. PubMed ID: 19454448
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of oral and gastrointestinal mucositis: ESMO clinical recommendations.
    Peterson DE; Bensadoun RJ; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():174-7. PubMed ID: 19454447
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeted drugs take centre stage at US cancer meeting.
    McCarthy M
    Lancet; 2001 May; 357(9268):1593. PubMed ID: 11377652
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
    Herrstedt J; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():156-8. PubMed ID: 19454442
    [No Abstract]   [Full Text] [Related]  

  • 12. Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
    Pacini F; Castagna MG; Brilli L; Pentheroudakis G;
    Ann Oncol; 2009 May; 20 Suppl 4():143-6. PubMed ID: 19454437
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of febrile neutropenia: ESMO clinical recommendations.
    Marti FM; Cullen MH; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():166-9. PubMed ID: 19454445
    [No Abstract]   [Full Text] [Related]  

  • 14. [Overview on the behalf of the Society for Arterial Infusion Chemotherapy Research].
    Taguchi T
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):919-22. PubMed ID: 2730031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESMO Clinical Practice Guidelines on palliative care: advanced care planning.
    Schrijvers D; Cherny NI;
    Ann Oncol; 2014 Sep; 25 Suppl 3():iii138-42. PubMed ID: 25210082
    [No Abstract]   [Full Text] [Related]  

  • 16. The challenges of oral agents as antineoplastic treatments.
    Given BA; Spoelstra SL; Grant M
    Semin Oncol Nurs; 2011 May; 27(2):93-103. PubMed ID: 21514479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congress of the American Society of Clinical Oncology].
    André T
    J Chir (Paris); 2002 Oct; 139(5):300-3. PubMed ID: 12410132
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy implications of oral agents.
    Spoelstra SL; Given BA; Given CW; Grant M
    Semin Oncol Nurs; 2011 May; 27(2):161-5. PubMed ID: 21514485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fertility preservation during treatment is a growing issue for women.
    Rowan K
    J Natl Cancer Inst; 2010 Mar; 102(5):294-6. PubMed ID: 20173119
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of cancer pain: ESMO clinical recommendations.
    Jost L; Roila F;
    Ann Oncol; 2009 May; 20 Suppl 4():170-3. PubMed ID: 19454446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.